Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.
about
Uremic Toxins - Novel Arrhythmogenic Factor in Chronic Kidney Disease - Related Atrial FibrillationChronic Kidney Disease and Fibrosis: The Role of Uremic Retention SolutesThe balance of powers: Redox regulation of fibrogenic pathways in kidney injuryCellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its ComorbiditiesPerspectives on systems biology applications in diabetic kidney diseaseManagement of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapyManagement of the cardiorenal syndrome in decompensated heart failureGut Bacteria and Hydrogen Sulfide: The New Old Players in Circulatory System HomeostasisIndoxyl Sulfate-Review of Toxicity and Therapeutic StrategiesThe microbiota and chronic kidney diseases: a double-edged swordCrosstalk between the unfolded protein response and NF-κB-mediated inflammation in the progression of chronic kidney diseaseMetabolomics and diabetes: analytical and computational approachesThe aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney diseaseNrf2 protects against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced oxidative injury and steatohepatitisUntargeted plasma metabolite profiling reveals the broad systemic consequences of xanthine oxidoreductase inactivation in miceIndoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectinChronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate.Triggering of suicidal erythrocyte death by uremic toxin indoxyl sulfate.The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor.Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.The Effect of Diet on the Survival of Patients with Chronic Kidney Disease.Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary studyTiming of dialysis initiation in transplant-naive and failed transplant patientsp-Cresol and cardiovascular risk in mild-to-moderate kidney diseaseThe production of p-cresol sulfate and indoxyl sulfate in vegetarians versus omnivores.Novel method for simultaneous determination of p-cresylsulphate and p-cresylglucuronide: clinical data and pathophysiological implications.The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition.Podocyte injury caused by indoxyl sulfate, a uremic toxin and aryl-hydrocarbon receptor ligand.Analytical approaches to metabolomics and applications to systems biologyEstimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight uremic solutes in chronic kidney diseaseMeta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal FailureIndoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stressThe Influence of Dietary Protein Intake on Mammalian Tryptophan and Phenolic Metabolites.p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney diseaseThe colon: an overlooked site for therapeutics in dialysis patients.An update on uremic toxins.Decrease in irisin in patients with chronic kidney disease
P2860
Q26747869-EDBDC668-ABF6-4B9B-8D7F-B774F2D54EB1Q26784008-04E22579-7B8F-4F3F-99C2-991CA90F06AFQ26786137-13C511F1-02BC-474C-9776-7604C618B92CQ26798487-0E132F68-00E8-490D-8113-578463F56C9BQ26823206-A42118D0-9F35-41BD-BBDF-D4BCC81B64A3Q26859689-A344EF33-2954-4BFF-8DA9-31973325E94AQ27028203-D1B6D6CD-DEB7-4F8E-8F44-52735AD5A5BEQ28066350-7BBF0B90-1B9A-4D9E-B1B3-7CE7A46D8689Q28075033-D8FD1A95-05B4-4A5F-899B-D14B6AC73D7CQ28078306-D3406B8F-915E-4E5E-A6BC-D1EC2E2E4088Q28080433-B9AC17F4-B9AB-4B7E-AC8A-57A86200E030Q28084835-F61B49E2-5D72-43BC-8833-EF591DC81172Q28382992-7E7F5628-06FC-44CF-8EEF-A5BE3B3AC5F7Q28392304-E7349FCE-29F6-475A-821C-971B5B2DC3D6Q28480520-9FDF7D30-72F3-436F-A2A5-8F0D8341A33DQ30497600-4639145F-D855-41D9-81EC-DBBB7F321B82Q31076633-415C1CDC-1DD9-4055-A39A-70137DE70571Q31142636-5F060074-E277-4A05-A3C6-092D4746B875Q33587787-59B90C6A-5550-4A91-B01F-294E387CC14EQ33613115-BC6950EF-397F-4615-AD65-D4F81845E79BQ33749467-08FD19C2-6D39-49AB-9E46-AA02844ECFAFQ33749490-1A60EC13-2E7E-485C-88BF-51AD723593E3Q33793516-4A4D523E-9C1A-4450-AF24-188A6E843BC1Q33919866-010CD192-8BF5-4358-99A7-8311D15C3BEDQ33944858-8810E54F-35E3-4270-B8BF-0FF6807DECE5Q34031430-1F6C981C-1832-4E3D-A076-376CFB185E92Q34100425-D766CEAC-09F9-4B31-A315-6621E734FB83Q34103477-B430FEE1-5786-454A-9162-C70A9E5F6F65Q34221944-F4C6C0F9-9F88-4DCA-8F77-059F3C3E0CC2Q34227115-BDA49BE1-2372-485E-A7D1-A777301B367DQ34340503-A7351E66-77AE-482B-87D3-4C890CFF4939Q34406428-2FFCCE6B-73C3-4DDA-A044-4B0A10B2C592Q34484986-CB7C2ADD-6259-4CA8-9E80-563E9559FA2FQ34497254-09D04DB3-D67E-4A69-A114-2D0D09B8A8D4Q34498094-55B20468-53BD-4A56-8790-6BC03F433C5FQ34593224-8FB09650-7170-4044-A31E-EBE2C8B612B3Q34595154-B091C62F-4A5C-47F0-A3D0-55CD3E2C6ECAQ34607428-37B7C800-F7A0-41C0-A81F-95A5D309C90EQ34641464-23946E7A-F832-4C98-AB05-9B87EDC1C4B2Q34718513-7F9022FD-4E39-4079-927D-903CFA55C21C
P2860
Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum indoxyl sulfate is assoc ...... ronic kidney disease patients.
@en
Serum indoxyl sulfate is assoc ...... ronic kidney disease patients.
@nl
type
label
Serum indoxyl sulfate is assoc ...... ronic kidney disease patients.
@en
Serum indoxyl sulfate is assoc ...... ronic kidney disease patients.
@nl
prefLabel
Serum indoxyl sulfate is assoc ...... ronic kidney disease patients.
@en
Serum indoxyl sulfate is assoc ...... ronic kidney disease patients.
@nl
P2093
P2860
P356
P1476
Serum indoxyl sulfate is assoc ...... ronic kidney disease patients.
@en
P2093
Daniela V Barreto
European Uremic Toxin Work Group (EUTox)
Fellype C Barreto
Gabriel Choukroun
Griet Glorieux
Mohammed Temmar
Natalie Meert
Sophie Liabeuf
Ziad A Massy
P2860
P304
P356
10.2215/CJN.03980609
P577
2009-08-20T00:00:00Z